Research into lung cancer
At Institut Curie, all patients suffering from lung cancer may be eligible for clinical trial protocols; these protocols are offered at the start of treatment or as the disease progresses, and may allow patients to receive the most innovative treatments that are not yet on offer and still under assessment, or those that are most suited to a specific situation.
These trial protocols are often conducted by French or European cooperative groups; they are known as multicenter trials, which sometimes require the participation of several hundred patients.
Other trials are conducted directly by the teams of physicians and researchers in the laboratories of Institut Curie Research Center, using blood or tumor samples taken as part of normal treatment, in order to characterize the biological mechanisms of cancer. The benefits and risks are always explained to the patient by the medical team.
Participation in a clinical trial protocol is highly controlled, and the interests of each patient are paramount.